Maturation & Accelerating Translation With Industry (MATWIN)

At a Glance
  • Status: Active Consortium
  • Year Launched: 2009
  • Initiating Organization: Maturation and Accelerating Translation with Industry
  • Initiator Type: Third-party organization
  • Disease focus:
    Oncology
  • Location: Europe
MATWIN

Abstract

The Maturation & Accelerating Translation with Industry (MATWIN) platform is unique in Europe. At this early stage of research, it supports the promotion of research through a collaborative, translational process with oncology research teams and major equipment manufacturers.

Mission

MATWIN does the following:

Structure & Governance

The International Board is a strategic body of the MATWIN program. Chaired by Josy Reiffers, president of MATWIN and Unicancer, it brings together academic opinion leaders in oncology from across Europe and heads of pharmaceutical companies that are MATWIN partners.

The national recovery organizations (e.g., Inserm Transfert, FIST, INCa) are permanent guest members of the International Board. They listen to the auditions but do not participate in the deliberations on projects. The quality of the International Board reflects the commitment of all partners, particularly industrialists. The International Board is unique in Europe in the environment of research and innovation. All of its members assemble once a year to meet the challenge of maturation in oncology. As part of the call for applications launched MATWIN in March-April of year n-1, the International Board then meets the following year in May.

The Steering Committee is also a strategic body of the program. This multidisciplinary committee brings together complementary skills and experiences reflect the continuum of research. Its roles are as follows:

Between 2009 and 2014 (fifth call for applications included):

Points of Contact

Institut Bergonié
229 cours de l’Argonne
33076 Bordeaux Cedex - France
phone: 05 35 54 19 36
email: contact@matwin.org

Sponsors & Partners

Amgen

AstraZeneca

Bayer HealthCare

Bristol-Myers Squibb

Caisse des Dépôts et Consignations

Cancéropôle Grand Sud-Ouest

Celgene

GlaxoSmithKline

Gustav Roussy

Institut National Du Cancer (INCA)

Merck-Serono

Novartis

Pierre Fabre

Roche

Sanofi

UNICANCER


Last Updated: 04/22/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.